Currently out of the existing stock ratings of Andrew Ranieri, 1235 are a BUY (49.72%), 1117 are a HOLD (44.97%), 132 are a SELL (5.31%).

Andrew Ranieri

Work Performance Price Targets & Ratings Chart

Analyst Andrew Ranieri works at MORGAN STANLEY with a stock forecast success ratio of 37.5% fulfilled within 29.75 days on average.

Andrew Ranieri’s has documented 180 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GMED, Globus Medical at 09-Nov-2022.

Wall Street Analyst Andrew Ranieri

Analyst best performing recommendations are on TMCI (TREACE MEDICAL CONCEPTS).
The best stock recommendation documented was for TMCI (TREACE MEDICAL CONCEPTS) at 5/26/2021. The price target of $32 was fulfilled within 1 day with a profit of $2.43 (8.22%) receiving and performance score of 82.18.

Average potential price target upside

of $15.86 (4.82%) on ISRG (INTUITIVE SURGICAL).
of $8.75 (14.44%) on HAE (HAEMONETICS).
of $7.63 (5.35%) on HRC (HILL-ROM HOLDINGS).

AGTI Agiliti BVS Bioventus GMED Globus Medical HAE Haemonetics HRC Hill-Rom Holdings ISRG Intuitive Surgical NPCE Neuropace NUVA NuVasive SIBN Si-Bone SYK Stryker TMCI Treace Medical Concepts ZBH Zimmer Biomet Holdings ATEC Alphatec Holdings AVNS Avanos Medical BAX Baxter International IART Integra LifeSciences Holdings NVST Envista Holdings Corp OM Outset Medical TFX Teleflex orporated STVN Stevanato Group SpA

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

John Ransom (RAYMOND JAMES)